Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FH5EF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,890
Award facts
- Contract value 100% obligated
- $9,889.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,889.86 by the Defense Logistics Agency on September 3, 2025, for the supply of Entyvio 300 mg vials. The contract carries an ultimate completion date of September 24, 2025, and was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates consistent success in competing for federal pharmaceutical procurements across diverse therapeutic categories, including specialty medications, injections, and biologics. This award reflects the company's ongoing role in meeting the pharmaceutical supply requirements of military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FH5EF?
SPE2DB25FH5EF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FH5EF worth?
The government has obligated $9,890 on SPE2DB25FH5EF.
Is contract SPE2DB25FH5EF an order under another contract?
Yes. SPE2DB25FH5EF is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5EF competed?
The extent of competition for SPE2DB25FH5EF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award